MK-677 cycling claims on TikTok: what the data actually shows

What did @tonyhuge.official actually say?

Tony Huge laid out a specific MK-677 protocol: five days on, two days off, run indefinitely, paired with something he calls "slim pills" to counteract insulin resistance. His exact framing was that this combination produces "higher growth hormone levels" while canceling "the insulin desensitization that happens from normal growth hormone use." He also said the compounds "were basically made to use forever." That last line is doing a lot of heavy lifting, and it deserves serious scrutiny.

To be clear about what MK-677 actually is: it is a ghrelin receptor agonist that stimulates pituitary release of growth hormone and IGF-1. It is not a SARM, despite being frequently grouped with them online. It is not approved by the FDA for any indication. It is an investigational compound with a research trail that is real but limited in long-term human safety data.

Does the science back this up?

Partially, but not in the way the video frames it. The mechanism is real. MK-677 does increase growth hormone pulse frequency and IGF-1 levels. The concern about chronic GH elevation causing insulin resistance is also real and documented. But the "five days on, two days off fixes everything" claim has no peer-reviewed support behind it.

A randomized controlled trial by Nass et al. (2008, Annals of Internal Medicine) studied MK-677 in older adults over two years and found meaningful increases in IGF-1 alongside increased fasting glucose and insulin resistance. That trial ran on a continuous daily protocol, so it does not tell us whether cycling mitigates these effects, but it also does not suggest a simple fix exists. The claim that a specific cycling pattern eliminates metabolic risk is not established in any published literature. Murphy et al. (1998, Journal of Clinical Endocrinology and Metabolism) showed GH and IGF-1 increases but did not test intermittent dosing for side effect mitigation.

What did they get wrong (or right)?

Credit where it is due: the underlying concern about chronic GH exposure and insulin sensitivity is scientifically legitimate. That is not bro-science, that is basic endocrinology, and it is reasonable to think about mitigation strategies.

What is wrong is the confidence. Saying there is a "no-side effect approach" based on personal experience and anecdote is not a clinical finding. It is an n-of-1 claim dressed up as a protocol. The "slim pills" recommendation is particularly concerning because it is vague, unnamed, and presented as though combining an unregulated compound with another unspecified product produces a synergistic, validated result. No study supports this stack. Recommending unidentified supplements to counteract the metabolic effects of an investigational compound, without naming ingredients or referencing any safety data, is a pattern that has led to real harm in sports supplement contexts. Haller et al. (2005, American Journal of Medicine) documented cardiovascular events tied to poorly characterized supplement stacks. The "made to use forever" framing is simply not defensible given the current evidence base.

What should you actually know?

MK-677 is being studied for legitimate indications including growth hormone deficiency and muscle wasting, but it is not approved for these uses. The side effect profile is real and includes fluid retention, increased appetite, elevated fasting glucose, and potential impacts on insulin sensitivity with longer use. These are not solvable by a cycling calendar alone.

If you are interested in GH-axis peptides for recovery or body composition, this conversation belongs with a licensed clinician who can assess your metabolic baseline, not a TikTok comment thread. Anyone offering to "personally help you achieve your muscle building goals" through a social media comment is not providing medical oversight. The appropriate setting for evaluating compounds like MK-677 involves baseline labs, monitored IGF-1 levels, and fasting glucose tracking. A five-on, two-off protocol may reduce cumulative exposure, but calling it side-effect-free is a claim that simply is not supported by data.